United Therapeutics And MannKind Announce Collaboration For Pulmonary Hypertension Products

Author's Avatar
Sep 04, 2018
Article's Main Image

Exclusive license agreement for Treprostinil Technosphere®; $95 million in upfront and milestone payments

Research agreement for additional products for additional $10 million

PR Newswire